Central venous Access device SeCurement and Dressing Effectiveness (CASCADE) in paediatrics: Protocol for pilot randomised controlled trials

BMJ Open

Volumn 6, Issue 6, 2016, Pages

  Ullman, Amanda J ^a,b   Kleidon, Tricia ^b,c   Gibson, Victoria ^b,c   Long, Debbie A ^b,c   Williams, Tara ^b,c   McBride, Craig A ^b,c,d   Hallahan, Andrew ^b,c,d   Mihala, Gabor ^a,b   Cooke, Marie ^a,b   Rickard, Claire M ^a,b  

^a GRIFFITH UNIVERSITY   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c LADY CILENTO CHILDREN S HOSPITAL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE ADHESIVE; POLYURETHAN;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; BLOODSTREAM INFECTION; CATHETER INFECTION; CENTRAL VENOUS ACCESS DEVICE; CENTRAL VENOUS CATHETER; CHILD; CONTROLLED STUDY; DEVICE FAILURE; FEASIBILITY STUDY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DEVICE COMPLICATION; OCCLUSION; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PEDIATRICS; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SUTURE; VEIN THROMBOSIS; ADVERSE DEVICE EFFECT; BANDAGE; CENTRAL VENOUS CATHETERIZATION; CLINICAL PROTOCOL; FEMALE; HOSPITAL; INCIDENCE; INDWELLING CATHETER; MALE; PROCEDURES; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

AUSTRALIA; BANDAGES; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CENTRAL VENOUS CATHETERS; CHILD; CLINICAL PROTOCOLS; EQUIPMENT FAILURE; FEASIBILITY STUDIES; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; INCIDENCE; MALE; PILOT PROJECTS; POLYURETHANES; TREATMENT OUTCOME;

EID: 84973571889     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-011197     Document Type: Article

References (48)

1. Robinson JL, Casey LM, Huynh HQ, et al. Prospective cohort study of the outcome of and risk factors for intravascular catheter-related bloodstream infections in children with intestinal failure. JPEN J Parenter Enteral Nutr 2014;38:625-30.
2. Intravenous Nursing New Zealand. Provisional infusion therapy standards of practice. In: O'Hara C, ed. Auckland: Intravenous Nursing New Zealand, 2012.
3. Frasca D, Dahyot-Fizelier C, Mimoz O. Prevention of central venous catheter-related infection in the intensive care unit. Crit Care 2010;14:212.
4. Pittiruti M, Hamilton H, Biffi R, et al. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications). Clin Nutr 2009;28:365-77.
5. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011;52:e162-93.
6. Loveday HP, Wilson JA, Pratt RJ, et al. epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2014;86(Suppl 1):S1-70.
7. Ruebner R, Keren R, Coffin S, et al. Complications of central venous catheters used for the treatment of acute hematogenous osteomyelitis. Pediatrics 2006;117:1210-15.
8. Perdikaris P, Petsios K, Vasilatou-Kosmidis H, et al. Complications of Hickman-Broviac catheters in children with malignancies. Pediatr Hematol Oncol 2008;25:375-84.
9. Cesaro S, Corrò R, Pelosin A, et al. A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases. Ann Hematol 2004;83:183-8.
10. Ullman AJ, Marsh N, Mihala G, et al. Complications of central venous access devices: a systematic review. Pediatrics 2015;136:e1331-44.
11. Ross T. A survival guide for health research methods. Berkshire, UK: Open University Press, 2012.
12. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006;81:1159-71.
13. Ullman AJ, Long DA, Rickard CM. Prevention of central venous catheter infections: a survey of paediatric ICU nurses' knowledge and practice. Nurse Educ Today 2014;34:202-7.
14. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355:2725-33.
15. Ullman AJ, Cooke M, Rickard C. Examining the role of securement and dressing products to prevent central venous access device failure: a narrative review. J Assoc Vasc Access 2015;20:99-110.
16. Frey AM, Schears GJ. Why are we stuck on tape and suture? A review of catheter securement devices. J Infus Nurs 2006;29:34-8.
17. Orgel E, Ji L, Pastor W, et al. Infectious morbidity by catheter type in neutropenic children with cancer. Pediatr Infect Dis J 2014;33:263-6.
18. Ullman AJ, Cooke ML, Mitchell M, et al. Dressings and securement devices for central venous catheters (CVC). Cochrane Database Syst Rev 2015;9:CD010367.
19. Yamamoto AJ, Solomon JA, Soulen MC, et al. Sutureless securement device reduces complications of peripherally inserted central venous catheters. J Vasc Interv Radiol 2002;13:77-81.
20. Teichgräber UK, de Bucourt M, Gebauer B, et al. Effectiveness of sutureless percutaneous placement of cuffed tunneled hemodialysis catheters applying StatLock attachment devices. J Vasc Access 2011;12:17-20.
21. Timsit J, Schwebel C, Bouadma L, et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter related sepsis in critically ill adults: a randomized controlled trial. JAMA 2009;301:1231-41.
22. Saijo F, Mutoh M, Kurihara M, et al. Effect of the sutureless stabilization device, SorbaView SHIELD, on the peripherally inserted central catheter. Jpn J Surg Metab Nutr 2014;48:107-13.
23. Singer AJ, Thode HCJ. A review of the literature on octylcyanoacrylate tissue adhesive. Am J Surg 2004;187: 238-48.
24. Wilkinson JN, Sheikh N, Jayamaha J. Tissue adhesive as an alternative to sutures for securing central venous catheters. Anaesthesia 2007;62:969-70.
25. Wilkinson JN, Fitz-Henry J. Securing epidural catheters with Histoacryl glue. Anaesthesia 2008;63:324.
26. Marsh N, Webster J, Flynn J, et al. Securement methods for peripheral venous catheters: a randomised controlled pilot trial. J Vasc Access 2015;16:237-44.
27. Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:a1655
28. Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract 2004;10:307-12.
29. Arain M, Campubell MJ, Cooper CL, et al. What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol 2010;10:67.
30. Thabane L, Ma J, Chu R, et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol 2010;10:1.
31. Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health 2008;31:180-91.
32. Centers for Disease Control and Prevention. National healthcare safety network device associated module: CLABSI. Atlanta: Government USoA, 2014:1-9.
33. Tuffaha H, Rickard C, Webster J, et al. Cost-effectiveness analysis of clinically indicated versus routine replacement of peripheral intravenous catheters. Appl Health Econ Heath Policy 2014;12: 51-8.
34. Ho KM, Litton E. Use of chlohexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J Antimicrob Chemother 2006;58:281-7.
35. Broadhurst D, Moureau N, Ullman AJ. Central venous access devices site care practices: an international survey of 34 countries. J Vasc Access 2016;17:78-86.
36. Fratino G, Molinari AC, Parodi S, et al. Central venous catheter-related complications in children with oncological/ hematological diseases: an observational study of 418 devices. Ann Oncol 2005;16:648-54.
37. Cecinati V, Brescia L, Tagliaferri L, et al. Catheter-related infections in pediatric patients with cancer. Eur J Clin Microbiol Infect Dis 2012;31:2869-77
38. Reichman DE, Greenberg JA. Reducing surgical site infections: a review. Rev Obstet Gynecol 2009;2:212-21.
39. Advani S, Reich NG, Sengupta A, et al. Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: extending risk analyses outside the intensive care unit. Clin Infect Dis 2011;52:1108-15.
40. Lorente L, Huidobro MS, Martín MM, et al. Accidental catheter removal in critically ill patients: a prospective and observational study. Crit Care 2004;8:R229-33.
41. Jumani K, Advani S, Reich NG, et al. Risk factors for peripherally inserted central venous catheter complications in children. JAMA Pediatr 2013;167:429-35.
42. Rickard CM, Marsh NM, Webster J, et al. Intravascular device administration sets: replacement after standard versus prolonged use in hospitalised patients-a study protocol for a randomised controlled trial (The RSVP Trial). BMJ Open 2015;5:e007257.
43. Kimberlin CL, Winterstein AG. Validity and reliability of measurement instruments used in research. Am J Health Syst Pharm 2008;65:2276-84.
44. Rothwell PM. Factors that can affect the external validity of randomised controlled trials. PLoS Clin Trials 2006;1:e9.
45. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010;152:726-32.
46. National Health and Medical Research Council, the Australian Research Council, the Australian Vice-Chancellors' Committee. National statement on ethical conduct in human research. Canberra: Australia Co, 2013.
47. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg 2011;9:672-7.
48. Webster J, Gillies D, O'Riordan E, et al. Gauze and tape and transparent polyurethane dressings for central venous catheters (review). Cochrane Database Syst Rev 2011;(11): CD003827.